These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 19605683)
1. Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Chalhoub N; Zhu G; Zhu X; Baker SJ Genes Dev; 2009 Jul; 23(14):1619-24. PubMed ID: 19605683 [TBL] [Abstract][Full Text] [Related]
2. Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects. Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN Biol Psychiatry; 2010 Jun; 67(11):1017-25. PubMed ID: 20163786 [TBL] [Abstract][Full Text] [Related]
3. Striking the balance between PTEN and PDK1: it all depends on the cell context. Iwanami A; Cloughesy TF; Mischel PS Genes Dev; 2009 Aug; 23(15):1699-704. PubMed ID: 19651981 [TBL] [Abstract][Full Text] [Related]
4. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
5. Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic Activity of PDK1 in Jurkat Cells. Yang KJ; Piao L; Shin S; Shin SY; Li Y; Lee H; Tran Q; Park J; Hong S; Brazil DP; Hemmings BA; Kim SH; Park J Anticancer Res; 2017 Oct; 37(10):5415-5423. PubMed ID: 28982851 [TBL] [Abstract][Full Text] [Related]
6. PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Feng Q; Di R; Tao F; Chang Z; Lu S; Fan W; Shan C; Li X; Yang Z Mol Cell Biol; 2010 Jul; 30(14):3711-21. PubMed ID: 20457809 [TBL] [Abstract][Full Text] [Related]
7. Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma. Scortegagna M; Ruller C; Feng Y; Lazova R; Kluger H; Li JL; De SK; Rickert R; Pellecchia M; Bosenberg M; Ronai ZA Oncogene; 2014 Aug; 33(34):4330-9. PubMed ID: 24037523 [TBL] [Abstract][Full Text] [Related]
8. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Vasudevan KM; Barbie DA; Davies MA; Rabinovsky R; McNear CJ; Kim JJ; Hennessy BT; Tseng H; Pochanard P; Kim SY; Dunn IF; Schinzel AC; Sandy P; Hoersch S; Sheng Q; Gupta PB; Boehm JS; Reiling JH; Silver S; Lu Y; Stemke-Hale K; Dutta B; Joy C; Sahin AA; Gonzalez-Angulo AM; Lluch A; Rameh LE; Jacks T; Root DE; Lander ES; Mills GB; Hahn WC; Sellers WR; Garraway LA Cancer Cell; 2009 Jul; 16(1):21-32. PubMed ID: 19573809 [TBL] [Abstract][Full Text] [Related]
9. 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Maurer M; Su T; Saal LH; Koujak S; Hopkins BD; Barkley CR; Wu J; Nandula S; Dutta B; Xie Y; Chin YR; Kim DI; Ferris JS; Gruvberger-Saal SK; Laakso M; Wang X; Memeo L; Rojtman A; Matos T; Yu JS; Cordon-Cardo C; Isola J; Terry MB; Toker A; Mills GB; Zhao JJ; Murty VV; Hibshoosh H; Parsons R Cancer Res; 2009 Aug; 69(15):6299-306. PubMed ID: 19602588 [TBL] [Abstract][Full Text] [Related]
10. Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice. Kilic U; Caglayan AB; Beker MC; Gunal MY; Caglayan B; Yalcin E; Kelestemur T; Gundogdu RZ; Yulug B; Yılmaz B; Kerman BE; Kilic E Redox Biol; 2017 Aug; 12():657-665. PubMed ID: 28395173 [TBL] [Abstract][Full Text] [Related]
11. Chemotactic activation of Dictyostelium AGC-family kinases AKT and PKBR1 requires separate but coordinated functions of PDK1 and TORC2. Liao XH; Buggey J; Kimmel AR J Cell Sci; 2010 Mar; 123(Pt 6):983-92. PubMed ID: 20200230 [TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes. Finlay DK; Sinclair LV; Feijoo C; Waugh CM; Hagenbeek TJ; Spits H; Cantrell DA J Exp Med; 2009 Oct; 206(11):2441-54. PubMed ID: 19808258 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321 [TBL] [Abstract][Full Text] [Related]
14. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment. Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK Nutr Cancer; 2011 Nov; 63(8):1226-34. PubMed ID: 21999454 [TBL] [Abstract][Full Text] [Related]
15. Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition. Goltsov A; Faratian D; Langdon SP; Mullen P; Harrison DJ; Bown J Cell Signal; 2012 Feb; 24(2):493-504. PubMed ID: 21996585 [TBL] [Abstract][Full Text] [Related]
16. Essential role of PDK1 in regulating endothelial cell migration. Primo L; di Blasio L; Roca C; Droetto S; Piva R; Schaffhausen B; Bussolino F J Cell Biol; 2007 Mar; 176(7):1035-47. PubMed ID: 17371830 [TBL] [Abstract][Full Text] [Related]